Aptinyx Inc reported $-21206000 in EBIT for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -15301000 28.41M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Biogen BIIB:US $ 858.6M 171.5M
Daiichi Sankyo 4568:JP 38.97B 6.8B
Eli Lilly And LLY:US $ 2055.2M 626.8M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Intra Cellular Therapies ITCI:US $ -77323830 8.18M
IONIS PHARMACEUT IONS:US $ -85849000 12.88M
Marinus Pharmaceuticals MRNS:US -19169000 4.32M
Neurocrine Biosciences NBIX:US $ 44.5M 23.3M
Novartis NOVN:VX 3.48B 77M
Ultragenyx Pharmaceutical RARE:US $ -89828000 7.05M
Vertex Pharmaceuticals VRTX:US $ 1055.71M 1092.07M